undefined undefined
NaN.000
NaN.00%
TherapeuticsMD (TXMD) has provided an announcement. TherapeuticsMD, Inc., a Nev...
05-11 04:34
Therapeutics MD press release (NASDAQ:TXMD): Q1 GAAP EPS of -$0.07. As of March 31, 2024, the Company’s cash and cash equivalents totaled $4.3 million. Gross license royalties totaled approximately $1...
05-11 04:17
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.07) per share. This is a 70.83 percent increase over losses of $(0.24) per share from the same period last year.
05-11 04:07
TherapeuticsMD (TXMD) has provided an announcement. TherapeuticsMD, Inc., a hea...
03-30 04:43
Therapeutics MD press release (NASDAQ:TXMD): FY net loss from continuing operations was $7.7 million, or $0.74 per basic and diluted share, compared to net income from continuing operations of $1.1 mi...
03-30 04:21
Understanding Value Stocks A value stock is traditionally defined in terms of ...
2023-11-27 10:43
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.05) by 160 percent. This is a 95.27 percent increase over losses of $(2.75) per share from
2023-11-15 05:57
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow traded up 0.19% to 34,159.14 while the NASDAQ rose 0.84% to 13,631.99. The S&P 500 also rose, gaining, 0.30% to 4,379.06.
2023-11-08 01:05
During the session on Thursday, 461 stocks hit new 52-week lows.
2023-09-22 00:08
What is the target price for TherapeuticsMD (TXMD)?The latest price target for ...
2023-08-17 23:48